Tech firms tell patent court to ignore Allergan deal with tribe
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
Mylan (MYL) and Aspen Report Launch of Generic Busulfex Injection
December 4, 2017 7:36 AM ESTMylan N.V. (NASDAQ: MYL) and its partner, Aspen, today announced the U.S. launch of Myleran (busulfan) Injection, 60 mg/10 mL (6 mg/mL) Single-dose Vial, a generic version of... More
